نتایج جستجو برای: anti tnf

تعداد نتایج: 402081  

Journal: :Journal of immunology 1998
D M Green J Trial H H Birdsall

We investigated mechanisms that increase motility and transendothelial trafficking of activated lymphocytes. Freshly isolated lymphocytes stimulated with immobilized anti-CD3 for 2 h migrate into polymerized collagen in 1.99+/-0.25-fold greater numbers and across confluent endothelial monolayers in 4.8+/-0.5-fold greater numbers compared with leukocytes incubated with non-specific IgG. Activate...

2014
Patrick Durez Pierre Vandepapeliere Pedro Miranda Antoaneta Toncheva Alberto Berman Tatjana Kehler Eugenia Mociran Bruno Fautrel Xavier Mariette Olivier Dhellin Bernard Fanget Stephane Ouary Géraldine Grouard-Vogel Marie-Christophe Boissier

OBJECTIVES Active immunization, or vaccination, with tumor necrosis factor (TNF)-Kinoid (TNF-K) is a novel approach to induce polyclonal anti-TNF antibodies in immune-mediated inflammatory diseases. This study was performed to transfer the proof of concept obtained in mice model of rheumatoid arthritis (RA) into human. We designed a pilot study to demonstrate the feasibility of therapeutic vacc...

Journal: :PLoS Computational Biology 2007
Simeone Marino Dhruv Sud Hillarie Plessner Philana Ling Lin John Chan JoAnne L. Flynn Denise E. Kirschner

The immune response to Mycobacterium tuberculosis (Mtb) infection is complex. Experimental evidence has revealed that tumor necrosis factor (TNF) plays a major role in host defense against Mtb in both active and latent phases of infection. TNF-neutralizing drugs used to treat inflammatory disorders have been reported to increase the risk of tuberculosis (TB), in accordance with animal studies. ...

2013
Mayur Sarangdhar Akash Kushwaha Jeanine Dahlquist Anil Jegga Bruce Aronow

Anti-TNF drugs are frequently associated with serious Adverse Events (AEs), which necessitates an improved understanding of individual factors that determine efficacy and safety of anti-TNF agents. We mined the US FDA's Adverse Event Reporting System (AERS) for anti-TNF-associated AEs to identify and stratify patient subgroups and drug combinations that exhibit specifically correlated complicat...

Journal: :British journal of haematology 2015
Hui Zhong James Bussel Karina Yazdanbakhsh

Tumour necrosis factor-α (TNF) is an inflammatory cytokine that is elevated in a number of autoimmune diseases including immune thrombocytopenia (ITP), a bleeding disorder characterized by low platelet counts. In vitro TNF blockade increases expansion of the regulatory T cell (Treg) IKZF2 (also termed Helios) subset in T cell-monocyte cocultures from healthy donors, but its role on proliferativ...

2015
Qingwei Zhao Dongsheng Hong Yi Zhang Yanlei Sang Zhihai Yang Xingguo Zhang Robert L. Barkin.

Tumor necrosis factor (TNF) is an important and pleiotropic cytokine which is also involved in the pathogenesis of inflammation in rheumatoid arthritis (RA), and RA treated with anti-TNF agents with a subsequent increase in hypertension risk is also observed in clinical trials. However, it is confusing that to what extent treatment with anti-TNF agents for RA might be associated with increasing...

Journal: :Journal of Crohn's & colitis 2015
Konstantinos Karmiris Peter Bossuyt Dario Sorrentino Tom Moreels Antonella Scarcelli Jesus Legido Iris Dotan Graham D Naismith Airi Jussila Jan C Preiss Wolfgang Kruis Andy C Y Li Guillaume Bouguen Henit Yanai Flavio Steinwurz Konstantinos H Katsanos Kavitha Subramaniam Dino Tarabar Ioannis V Zaganas Shomron Ben-Horin

BACKGROUND AND AIMS Cerebrovascular accidents [CVA] have rarely been reported in inflammatory bowel disease [IBD] patients treated with anti-tumour necrosis alpha [anti-TNF alpha] agents. Our aim here was to describe the clinical course of CVA in these patients. METHODS This was a European Crohn's and Colitis Organisation [ECCO] retrospective observational study, performed as part of the CONF...

2012
Janet Pope J. Carter Thorne Boulos Paul Haraoui Eliofotisti Psaradellis John Sampalis

BACKGROUND The chance of a good response in RA is attenuated in previous anti-TNF users who start new anti-TNF therapy compared to biologic naïve patients. In active RA, those with previous anti-TNF exposure compared to anti-TNF naïve may have different baseline disease activity and patient perceptions when starting a new anti-TNF treatment that could explain the observed response differences. ...

2015
Leslie R Harrold George W Reed Joel M Kremer Jeffrey R Curtis Daniel H Solomon Marc C Hochberg Jeffrey D Greenberg

OBJECTIVE We compared the effectiveness of abatacept (ABA) versus a subsequent anti-tumour necrosis factor inhibitor (anti-TNF) in rheumatoid arthritis (RA) patients with prior anti-TNF use. METHODS We identified RA patients from a large observational US cohort (2/1/2000-8/7/2011) who had discontinued at least one anti-TNF and initiated either ABA or a subsequent anti-TNF. Using propensity sc...

Journal: :Chemosensors 2021

Assessing tumour necrosis factor-? (TNF-?) levels in the human body has become an essential tool to recognize heart failure (HF). In this work, label-free, rapid, easy use ImmunoFET based on ion-sensitive field effect transistor (ISFET) was developed for detection of TNF-? protein. Monoclonal anti-TNF-? antibodies (anti-TNF-? mAb) were immobilized ISFET gate made silicon nitride (Si3N4) after s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید